Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-cell receptors (TCRs) on CD4+ T-cells specific for grass pollen-derived peptides are the primary molecular sensors that initiate and drive the allergic immune response to grass pollen. These receptors recognize specific allergenic epitopes, such as those from the Phl p 1 and Phl p 5 proteins of Timothy grass, presented by Major Histocompatibility Complex (MHC) class II molecules on the surface of antigen-presenting cells (Wambre et al., 2012, Science Translational Medicine). In allergic individuals, the activation of these TCRs leads to the differentiation of Type 2 helper T-cells (Th2), which secrete pro-inflammatory cytokines like IL-4 and IL-13, ultimately resulting in IgE production and the clinical symptoms of hay fever and asthma (Larché et al., 2006, Nature Reviews Immunology). Therapeutic strategies, particularly allergen-specific immunotherapy (AIT), aim to modify the signaling through these TCRs to induce immunological tolerance. This process involves the induction of regulatory T-cells (Tregs) and the shifting of the immune response from a Th2 to a Th1 or regulatory profile (Akdis & Akdis, 2014, Journal of Allergy and Clinical Immunology). Monitoring the frequency and phenotype of these specific TCR-bearing cells using MHC tetramers is a vital tool for evaluating the success of desensitization treatments.
Induction of immune tolerance through T-cell anergy, clonal deletion, or the promotion of regulatory T-cells (Tregs) and immune deviation from a Th2 to a Th1 profile.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell receptor on CD4+ T-cell specific for grass pollen-derived peptide (TCR).